NCT00552214
Completed
Not Applicable
Evaluation of a TMA Assay for the Screening of HIV-1 RNA, HCV RNA and HBV DNA in Human Blood Donor Plasma Specimens
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations
- Sponsor
- Novartis
- Enrollment
- 10290
- Locations
- 1
- Primary Endpoint
- Sensitivity and Specificity
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The purpose of this study is to validate the performance characteristics of an assay that tests for HIV-1, HCV and HBV on an automated blood bank instrument for registration submission.
Investigators
Eligibility Criteria
Inclusion Criteria
- •An acceptable blood donation health history and an EIA negative donation sample result with licensed EIA procedures in routine use at each facility
Exclusion Criteria
- •A positive (reactive) HIV and/or HCV and/or HBV test
Outcomes
Primary Outcomes
Sensitivity and Specificity
Time Frame: 01 August 2007 to 31 December 2007
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Using HIV Risk Assessment Tool to Promote HIV Testing Among Men Who Have Sex With MenHIV/AIDSHIV InfectionsSocial MediaNCT03320239National Center for AIDS/STD Control and Prevention, China CDC4,500
Completed
Not Applicable
HIV Treatment-Readiness Measure (HTRM) ValidationHIV InfectionsNCT00686049University of North Carolina, Chapel Hill200
Completed
Not Applicable
Rapid Oral Test for Therapeutic Response in HIV/AIDS PatientsAIDS/HIV PROBLEMNCT01507142Gaia Medical Institute100
Completed
Not Applicable
Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study)HIV InfectionsNCT00615563Boehringer Ingelheim246
Completed
Not Applicable
Diagnosis of HIV and Early Antiretroviral Therapy Initiation Among HIV-1 Infected InfantsHIV InfectionsHivNCT03133728University of Alabama at Birmingham1,682